Bioline Rx Ltd Ord

(BLNEF)

By |

Profile

BioLine Rx Ltd is a clinical-stage biopharmaceutical company, which is engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. It offers products such as BL-1020 which is used to improve cognitive function in schizophrenia patients; BL-1040 for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, for non-surgical removal of skin lesions; BL-1021 for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is used for the treatment of inflammatory bowel disease. Geographically all the operations are functioned from the region of Israel.

Contact Information

Website: www.biolinerx.com
Email: IR@biolinerx.com
Main Phone: +972 86429100
Address: 2 HaMa'ayan Street
City / Town: Modi'in
Country: ISR
Postal Code: 7177871

Issuer Information

Exchange: GREY
CEO: Philip Serlin
Employees: 51
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 106,290,010.00 EPS (TTM) -0.27 PE Ratio N/A Exchange Greys